e-learning
resources
Barcelona 2013
Tuesday, 10.09.2013
Asthma drugs: new findings
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Interim analysis of post-marketing surveillance of omalizumab in Japan
K. Ohta, H. Yoshisue, Y. Aoki, T. Irokawa, M. Ishigaki, M. Adachi, T. Miyamoto (Tokyo, Japan)
Source:
Annual Congress 2013 –Asthma drugs: new findings
Session:
Asthma drugs: new findings
Session type:
Thematic Poster Session
Number:
4128
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
K. Ohta, H. Yoshisue, Y. Aoki, T. Irokawa, M. Ishigaki, M. Adachi, T. Miyamoto (Tokyo, Japan). Interim analysis of post-marketing surveillance of omalizumab in Japan. Eur Respir J 2013; 42: Suppl. 57, 4128
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Asthma management in a specialist setting: Results of a national survey
Source: International Congress 2016 – Monitoring airway diseases with clinical tools
Year: 2016
Priorities for asthma R&D in Europe: A systematic approach
Source: International Congress 2016 – Asthma points to ponder
Year: 2016
Asthma management among allergists in Italy: Results from a survey
Source: International Congress 2016 – Asthma: treatment, disease control, and quality of life
Year: 2016
The Italian registry for severe/uncontrolled asthma
Source: International Congress 2016 – Asthma: treatment, disease control, and quality of life
Year: 2016
Finding asthmatics suitable for omalizumab therapy in a district hospital
Source: Annual Congress 2013 –Phenotyping asthma: clinical severity, comorbid conditions response to treatment?
Year: 2013
Developing integrated mental health and asthma treatment protocol using quality improvement methods
Source: International Congress 2016 – Asthma points to ponder
Year: 2016
A national database study of the effectiveness of switching real-life asthma patients to fostair
Source: International Congress 2015 – New data on established treatments for asthma, COPD and bronchiectasis
Year: 2015
International perspectives on severe asthma: Current and future challenges in patient care
Source: International Congress 2016 – Asthma points to ponder
Year: 2016
Cost analysis of childhood asthma in Iran: A cost evaluation based on referral center data for asthma and allergies
Source: International Congress 2014 – More paediatric asthma
Year: 2014
A case diagnoed ACOS with omelizumab treatment
Source: International Congress 2016 – Clinical characteristics of asthma
Year: 2016
Management of asthma in patients discharged from A and E
Source: International Congress 2016 – Asthma points to ponder
Year: 2016
A multidisciplinary clinic for children with severe asthma: Clinical outcomes and healthcare utilization
Source: International Congress 2014 – More paediatric asthma
Year: 2014
An overview of patient adherence to asthma medication in Canada
Source: Annual Congress 2013 –Treatment and adherence to treatment of respiratory disease
Year: 2013
Asthma therapeutic management in the elderly: Pharmacoepidemiological approach in the E3N cohort
Source: International Congress 2015 – Treatment and control of respiratory disease
Year: 2015
Cost-effectiveness of FeNO- and web-based monitoring in pediatric asthma management
Source: International Congress 2015 – Paediatric asthma and allergy: e-health in management
Year: 2015
Guideline adherence and cost of asthma treatment at emergency department
Source: International Congress 2014 – Paediatric asthma: pharmacological and non-pharmacological management
Year: 2014
Improving paediatric asthma management through improved communication
Source: International Congress 2014 – Paediatric asthma: pharmacological and non-pharmacological management
Year: 2014
LATE-BREAKING ABSTRACT: Effectiveness of individualized self management support for children with asthma in Dutch outpatient clinics, preliminary results of a randomized controlled trial.
Source: International Congress 2014 – Paediatric asthma: pharmacological and non-pharmacological management
Year: 2014
Safety and tolerability of acute dosing of beta-blockers in asthma
Source: Annual Congress 2013 –Asthma and COPD management: novel clinical findings
Year: 2013
Prevalence of asthma and management of exacerbations in general practice (GP) after computerised Spanish guideline on the management of asthma (GEMA) and collaborative care environment
Source: International Congress 2015 – Management of asthma and COPD in primary care
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept